文献速递胃肠外科围术期管理与 ERAS

减重手术患者炎症相关生物标志物调节与表达变化:系统综述与Meta分析

Variation of modulation and expression of biomarkers associated with inflammation in bariatric surgery patients: A systematic review and meta-analysis.
PubMed 文献 · Surgery · 2023-08-24

该系统综述与Meta分析检索多个数据库至2022年1月,纳入96篇文章,其中87项研究(3533例参与者)进入Meta分析,评估减重手术前后五种炎症相关生物标志物的变化。结果显示术后1个月仅瘦素显著下降,术后12个月肿瘤坏死因子α、白细胞介素6、瘦素和白细胞介素1β均显著下降,但异质性高。

要点

  • 术后1个月仅瘦素显著下降(均差-20.71,95%CI -28.10至-13.32,P<.0001,I²=66.7%)。
  • 术后12个月肿瘤坏死因子α、白细胞介素6、瘦素和白细胞介素1β均显著下降,异质性高。
  • 手术类型在术后1个月和12个月对生物标志物未见显著差异。

核心结论

  • 本Meta分析提示Roux-en-Y胃旁路术和袖状胃切除术与术后1个月瘦素显著降低及术后12个月肿瘤坏死因子α、瘦素和白细胞介素1β显著降低相关。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE(via PubMed)、EMBASE(via Elsevier)、Cochrane Central Register of Controlled Trials、Latin American and Caribbean Literature on Health Sciences(via virtual health library)、Cumulative Index to Nursing and Allied Health Literature(via EBSCO)、Web of Science核心合集和Scopus(via Elsevier)数据库,并检查灰色文献,检索时间从建库至2022年1月。
  • 共纳入96篇文章,其中87项研究符合Meta分析标准,涉及3533例参与者。
  • 由三对评审员独立进行数据筛选、提取和质量评估,采用随机效应模型进行Meta分析、亚组分析和敏感性分析,使用I²统计量评估研究间异质性。

主要发现

  • Meta分析纳入五种生物标志物:肿瘤坏死因子α、白细胞介素6、瘦素、白细胞介素1β和脂多糖。
  • 术后1个月仅瘦素显示显著下降(均差-20.71;95%CI -28.10至-13.32,P<.0001;I²=66.7%),异质性中等。
  • 术后12个月肿瘤坏死因子α显著下降(均差-0.89;95%CI -1.37至-0.42,P=.0002;I²=94.7%),白细胞介素6显著下降(均差-1.62;95%CI -1.95至-1.29,P<.0001;I²=94.9%),瘦素显著下降(均差-28.63;95%CI -34.02至-23.25,P<.0001;I²=92.7%),白细胞介素1β显著下降(均差-2.46;95%CI -4.23至-0.68,P=.006;I²=98.3%),均异质性高。
  • 手术类型在术后1个月和12个月对生物标志物未显示显著差异,高质量研究结果未改变。
  • 在12个月测量中,肿瘤坏死因子α和瘦素的变化与体重指数相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 术后1个月瘦素分析异质性I²=66.7%,为中等异质性。
  • 术后12个月肿瘤坏死因子α分析异质性I²=94.7%,白细胞介素6分析异质性I²=94.9%,瘦素分析异质性I²=92.7%,白细胞介素1β分析异质性I²=98.3%,均为高异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bariatric surgery is an effective intervention that causes a series of metabolic changes related to inflammatory processes; however, the variation of biomarkers related to these processes is not entirely understood. Our objective was to investigate the variation of modulation and expression of biomarkers associated with inflammation in patients who underwent bariatric surgery. METHODS: We searched the MEDLINE (via PubMed), EMBASE (via Elsevier), Cochrane Central Register of Controlled Trials, Latin American and Caribbean Literature on Health Sciences (via virtual health library), Cumulative Index to Nursing and Allied Health Literature (via EBSCO), Web of Science core collection, and Scopus (via Elsevier) databases, and the gray literature was examined from inception to January 2022. Three pairs of reviewers performed data screening, extraction, and quality assessment independently. Meta-analysis with random effects models was used for general, subgroup, and sensitivity analyses. The I2 statistic was used to assess heterogeneity between studies. RESULTS: In total, 96 articles were included in this systematic review; of these, 87 studies met the criteria for the meta-analysis, involving 3,533 participants. Five biomarkers were included in the meta-analysis (tumor necrosis factor alpha; interleukin 6; leptin; interleukin 1 beta, and lipopolysaccharides). Only leptin showed a significant decrease in the first month after surgery (mean difference -20.71; [95% confidence interval: -28.10 to -13.32, P < .0001; I2 = 66.7%), with moderate heterogeneity. The 12 months after surgery showed a significant decrease in tumor necrosis factor alpha (mean difference -0.89; [95% confidence interval: -1.37 to -0.42], P = .0002; I2 = 94.7%), interleukin 6 (mean difference -1.62; [95% confidence interval: -1.95 to -1.29], P < .0001; I2 = 94.9%), leptin (mean difference -28.63; [95% confidence interval: -34.02 to -23.25], P < .0001; I2 = 92.7%), and interleukin 1 beta (mean difference -2.46; [95% confidence interval: -4.23 to -0.68], P = .006; I2 = 98.3%), all with high heterogeneity. The type of surgery did not show significant differences for the biomarkers at the first month and 12 months, and the results have not changed with high-quality studies. In the 12-month measurement, variations in tumor necrosis factor alpha and leptin were associated with body mass index. CONCLUSION: The findings of this meta-analysis suggest that Roux-en-Y gastric bypass and sleeve gastrectomy bariatric surgeries are associated with a significant reduction in leptin at 1 month after bariatric surgical intervention and tumor necrosis factor alpha, leptin, and interleukin 1 beta after 12 months.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Machado CR, Braun AM, Ceolin J, et al. Variation of modulation and expression of biomarkers associated with inflammation in bariatric surgery patients: A systematic review and meta-analysis. Surgery. 2023. PMID: 37633813. doi:10.1016/j.surg.2023.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。